 Claudia Dollins Main position/role: Executive Director, Global Regulatory Affairs Team, Precision Medicine and Companion Diagnostics, Bristol-Myers Squibb |
| Claudia currently heads the Global Regulatory Affairs team, Precision Medicine and Companion Diagnostics at Bristol-Myers Squibb. In her current role, she leads team that provides regulatory strategy support to the companion diagnostics and digital health elements of the BMS portfolio. Before joining BMS, she was responsible for the development and implementation of global regulatory strategies of companion diagnostics, medical devices and digital health products in the Merck Healthcare KGaA pipeline. She further served as a senior reviewer and acting chief of the hematology branch of the Office of In Vitro Diagnostics and Radiologic Health at the FDA. Claudia is a member of the EFPIA Precision Medicine Working Group. Claudia holds a PhD in Genetics and Genomics from Duke University Medical Center and completed postdoctoral training in Developmental Biology at the University of North Carolina, Chapel Hill. |
